Xiaoyu Chen

3PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 11, 2024
Reconstruction of unreported subgroup survival data with PD-L1-low expression in advanced/metastatic triple-negative breast cancer using innovative KMSubtraction workflow.

Yan Li, Xueyan Liang, Huijuan Li

|Jul 26, 2023
Cost-effectiveness of camrelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer.

Xueyan Liang, Xiaoyu Chen, Huijuan Li

|Sep 16, 2022
Atezolizumab plus bevacizumab versus nivolumab as first-line treatment for advanced or unresectable hepatocellular carcinoma: A cost-effectiveness analysis.

Yan Li, Xueyan Liang, Huijuan Li

Pageof 1

Frequent Collaborators

1 joint publications

Xueyan Liang

1 joint publications

Huijuan Li

1 joint publications

Yan Li